Year archive

Concord Drugs Limited — 2026 filings

All 6 regulatory filings released by Concord Drugs Limited (538965) in 2026, sourced directly from the official regulator.

6 Filings

2026 Period

2026 filings (6)

Filing	Released	Lang
Annual Secretarial Compliance report under Regulation 24(A) Regulatory Filings	2026-05-29	English
Financial Results for Year ending 31st March, 2026 Interim / Quarterly Report FY 2026	2026-05-29	English
Company has approved financial results for Quarter and year ending 31st March,2026 Interim / Quarterly Report FY 2026	2026-05-27	English
Company in its Board Meeting has approved financial results for period ended 31st March,2026 Interim / Quarterly Report FY 2026	2026-05-27	English
Company in its Board Meeting has approved financial results for period ended 31st March,2026 Interim / Quarterly Report FY 2026	2026-05-27	English
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Financial Results for year ending 31.03.2026 Regulatory Filings	2026-05-18	English